Jesús Castro-Marrero

Jesús Castro-Marrero, PhD, (also known as Jesus Castro) works at Cornell ME/CFS Collaborative Research Center, New York, US. His research focuses on Extracellular Vesicles/Exosomes biology and decoding differences in the mRNA and miRNA expression cargo from Extracellular Vesicles (EVs) and blood immune cells (peripheral blood mononuclear cells) before and after a 24 hour CPET challenge in a gender-specific manner in individuals with ME/CFS.

Previously, he was a Senior Research Associate in Biochemistry and Molecular Biology at the Vall d’Hebron University Hospital Research Institute (VHIR), Barcelona, Spain.

EUROMENE
Dr. Castro-Marrero is a Working Group Leader on Epidemiology of ME/CFS across Europe on behalf of the EUROMENE, a European Union not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Education

 * 1987 - B.S. in Biochemistry, School of Biological Sciences, University of Havana, Cuba
 * 1999 - Ph.D. in Biochemistry and Molecular Biology, Valladolid University School of Medicine, Spain

Notable studies

 * 2013, Screening NK-, B- and T-Cell phenotype and function in patients suffering from Chronic Fatigue Syndrome - (Full Text)
 * 2013, Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? - (Abstract)
 * 2014, Impact of the fibromyalgia in the chronic fatigue syndrome - (Abstract)
 * 2015, Does Oral Coenzyme Q10 Plus NADH Supplementation Improve Fatigue and Biochemical Parameters in Chronic Fatigue Syndrome? - (Full Text)
 * 2015, Diagnostic concordance between categorical and dimensional instrument to assess personality in chronic fatigue syndrome: PDQ-4+ and TCI-R - (Abstract)
 * 2015, Childhood trauma in Chronic Fatigue Syndrome: focus on personality disorders and psychopathology - (Abstract)
 * 2016, Gender Differences in Chronic Fatigue Syndrome - (Full Text)
 * 2017, The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE - (Full Text)
 * 2017, Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome - (Full Text)
 * 2017, Comorbidity in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Nationwide Population-Based Cohort Study - (Abstract)
 * 2018, Circadian rhythm abnormalities and autonomic dysfunction in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis - (Full Text)
 * 2018, Poor self‐reported sleep quality and health‐related quality of life in patients with chronic fatigue syndrome/myalgic encephalomyelitis - (Abstract)
 * 2018, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome – Evidence for an autoimmune disease - (Full Text)
 * 2018, Circulating extracellular vesicles as potential biomarkers in chronic fatigue syndrome/myalgic encephalomyelitis: an exploratory pilot study - (Full Text)
 * 2018, Dimensional Personality Assessment among a Chronic Fatigue Syndrome (CFS) sample with Personality Inventory for DSM-5 (PID-5) - (Abstract)
 * 2018, Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review - (Full text)
 * 2018, Low omega-3 index and polyunsaturated fatty acid status in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis - (Abstract)
 * 2019, Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a community-based cross-sectional study from Spain - (Full text)
 * 2020, Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis - (Full text)
 * 2020, Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender‐specific changes in the microRNA expression profiling in ME/CFS - (Full text)
 * 2020, Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology - (Full text)
 * 2020, Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: A pilot study - (Full text)
 * 2021, The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput epigenetic and gene expression studies - (Full text)

Online presence

 * PubMed
 * ResearchGate
 * Curriculum Vitae